SUMMARY The progress of proliferative sickle retinopathy (PSR) in 57 eyes treated by xenon arc photocoagulation has been compared with that in 41 comparison eyes. Angiographic assessment of the treated PSR lesions in 54 patients followed up for a mean period of 47 months (range months) revealed cessation of leakage in 44 (81 %), reduction of leakage in 8 (15 %), and no change in 2 (4 %). In the 41 comparison eyes more extensive perfused PSR occurred in 25 (60 %), no change in 8 (20) , and spontaneous improvement in 8 (20%). Autoinfarction of PSR lesions in comparison eyes was observed during the study period in 16 (39 %). Assessed Fluorescein angiographic assessment at the end of study periods varying from 8 to 65 months (mean 47 months) was performed in all patients except 2 developing retinal detachment (cases 26. 9  10  11  12  13  14  15  16   17  18  19  20  21   22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51 6/6 6/6 6/9 6/18 6/6 6/6 6/6 6/12 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/12 6/6 6/12 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/9 6/6 6/9 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/9 6/6 6/6 6/6 6/6 6/6 6/6 6/9 6/18 6/9 6/6 6/12* 6/24* 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/12* 6/12* 6/6 6/12* 6/6 6/18** 6/6 <6/60** 6/6 6/6 6/18 6/6 6/6 6/6 6/6 <6/60** 6/6 6/60** 6/9 6/1 8** 6/6 6/6 6/9 6/6 6/9 6/6 9 6/6 6/9 6/6 6/6 6/6 6/18* 6/9 6/12* 6/6 6/6 6/6 6/6 6/9 6/6 6/6 6/6 6/60 NPL 34) and one who was pregnant (case 15). In the remaining 54 patients leakage from the originally treated PSR lesion was considered to have ceased in 44 (81%), improved in 8 (15%), and persisted unchanged in 2 (4%).
CHOROIDAL NEOVASCULARISATION
In 31 patients fluorescein leakage subsequently developed at the site of photocoagulation, all of which showed fine vessel systems within the burn area apparently supplied by choroidal vessels and draining through either choroidal or retinal veins. In 19 patients these abnormal vessels were in the plane of the retina, and their fluorescence was separated from the surrounding normally perfused retina by a margin of nonfluorescence. These lesions were referred to as choroidoretinal neovascularisation (CRN), and an example is illustrated in Fig. 2 . In 12 patients the abnormal vessel system projected into the vitreous, and fluorescence from these lesions frequently overlay normal retina. These lesions were referred to as choroidovitreal neovascularisation (CVN), and an example is illustrated in Fig. 3 
HAEMORRHAGE
Preretinal haemorrhages occurred in 6 patients and were multiple in 3 patients, all of whom had received diathermy. Three patients (cases 20, 24, 53) developed haemorrhages in direct relationship to the diathermy burns, and two of these also developed preretinal haemorrhages in remote areas of the same eye. Two patients (cases 11, 52) developed preretinal haemorrhages in relation to CVN lesions 4 years after therapy, and 1 patient (case 38) developed two preretinal haemorrhages, one as an extension of a deep retinal haemorrhage, 16 and 26 months after therapy. Retinal haemorrhage confined to the burn area occurred in 9 patients. Neither form of haemorrhage extended into the vitreous or affected visual acuity. Vitreous haemorrhage occurred in the treatment eye in 8 patients, 4 of whom had choroidovitreal neovascularisation. In 1 of these (case 10) a limited vitreous haemorrhage occurred during photocoagulation of a CVN lesion, but in the remainder the haemorrhage occurred 11-3 years after therapy.
VITREORETINAL TRACTION
Vitreoretinal traction developed or became worse during the study in 7 patients. In 2 patients it was associated with epiretinal membranes and in 4 with posterior vitreous detachments. A retinal tear produced during therapy in one patient (case 8) was successfully sealed by further light coagulation at the same treatment session. Retinal detachment occurred in 2 patients both having had retreatment for a persistently perfused PSR lesion. In one (case 26) photocoagulation of a darkly pigmented area produced excessive heat release, with fracture of Bruch's membrane and an immediate subretinal haemorrhage which spread to the vitreous. This did not change for 1 month, but 4 months later a gradual blurring of vision occurred, and examination 1 year after the original treatment revealed no red reflex, no observable detail behind the lens, and inaccurate projection of light. The other patient (case 34) had apparently uneventful initial therapy but noted progressive deterioration of vision 1 year later, and examination 3 years after this revealed gross vitreoretinal traction and a total retinal detachment, which was unsuccessfully repaired with vitreoretinal surgery.
OTHER COMPLICATIONS OF THERAPY
Other complications in the treatment group included anterior uveitis, anterior segment ischaemia, partial third nerve palsies, haemorrhage, vitreoretinal changes, and retinal detachment.
Anterior uveitis occurred in 4 patients and settled promptly on systemic and topical steroid therapy. Anterior segment ischaemia occurred in 1 patient after scleral diathermy despite care being taken to avoid the long ciliary vessels or detachment of ocular muscles. This complication gradually settled on systemic and topical steroids, but signs of iris atrophy, irregularity of the pupil, and extensive anterior and posterior synechiae remained. Both anterior uveitis and anterior segment ischaemia were confined to patients treated by scleral diathermy and were not considered complications of photocoagulation.
Partial third nerve palsies followed retrobulbar injection of local anaesthetic in 7 patients, all resolving satisfactorily within 2-3 weeks. There was the clinical impression that this complication was more common in patients requiring larger volumes of anaesthetic for effective anaesthesia.
BEHAVIOUR OF COMPARISON EYE GROUP
Of the 47 comparison eyes gross pathology precluded satisfactory longitudinal observations on PSR in 6. Four had retinal detachment (cases 8, 35, 36, 41) and 1 gross vitreous fibrosis (case 22) on admission to the study, and 1 patient (case 5) developed a gross vitreous haemorrhage after initial examination. Of the remaining 41 eyes 10 developed PSR for the first time during the study period, and an increase in the number or size of PSR lesions occurred in a further 21 patients. Autoinfarcted PSR lesions were present on admission to the study in 6 patients and developed during the study in 16, three showing complete autoinfarction of all leaking lesions and 13 a combination of autoinfarction and progression. When angiographic assessments were compared at the beginning and end of the study in the 41 comparison eyes with adequate data, 25 (60%) indicated more extensive perfused PSR, 8 (20%) showed no change, and 8 (20%) improved. In 3 of the latter patients PSR developed and spontaneously infarcted during the study period. The comparison group showed preretinal haemorrhages in 3 eyes and vitreous haemorrhages in 7 eyes. One vitreous haemorrhage (case 5) followed trauma to an eye with perfused PSR, the significance of which was difficult to assess.
Visual acuity, measured at the first and last attendance during the study, decreased by 2 lines or more on the Snellen chart in 12/57 (21%) of the treatment group compared to 4/42 (10%) of the comparison group. Deterioration of 3 lines or more occurred in 5 (9%) and 2 (5%) respectively and was attributed in the treatment group to retinal detachment (2), vitreous organisation (1), vitreous haemorrhage (1), and possible macular oedema (1), and in the comparison group to vitreous haemorrhage (2) . The visual acuity in 1 patient in the treatment group (case 36) attributed to possible macular oedema subsequently improved to 6/12.
Discussion
The abnormal vessel systems that develop at the junction of vascular and avascular retina in sickle cell disease may compromise vision by causing vitreous haemorrhage and/or retinal detachment. Rendering these lesions avascular appears logical, and their characteristic anatomy, with feeding arterioles and draining veins, makes them amenable to closure by localised coagulation. Xenon arc, argon laser, diathermy, and cryopexy have been employed, the present study using the xenon arc with supplemental diathermy in some cases. The procedure included coagulation of the feeding arterioles after their identification by fluorescein angiography, followed by coagulation of the proliferative lesion. Certain complications attended repeated photocoagulation. Increased organisation and rigidity of the vitreous body with subsequent traction on the internal limiting membrane of the retina of the posterior pole occurred in 7 patients, 6 of whom had had 2 or more treatment sessions. Posterior vitreous detachment occurred in 4 patients, but traction retinal detachment was not observed. In 1 patient with 4 treatment sessions gross vitreous fibrotic changes occurred with vitreoretinal traction and recurrent vitreous haemorrhages originating in the choroid or deep retina peripheral to the coagulated area. Retreatment of a darkly pigmented area in another resulted in retinal detachment and blindness. To diminish these dangers the minimally effective power of the coagulator should be used in retreatment of pigmented areas.
Other complications related to therapy included transient partial third nerve palsies, anterior uveitis and anterior segment ischaemia, and haemorrhages. The duration of burn with the xenon arc photocoagulator used (1 5-3-0 seconds), necessitated the routine use of retrobulbar anaesthesia. Partial third nerve palsies which developed in 7 patients were probably related to the volume or siting of retrobulbar injections and all resolved satisfactorily. Anterior uveitis and anterior segment ischaemia were confined to patients receiving diathermy and should probably not be considered complications o1 xenon arc photocoagulation. Multiple preretinal haemorrhages were also confined to the diathermy group. A single preretinal haemorrhage developed in 2 patients after xenon arc photocoagulation, but neither these nor the retinal haemorrhages confined to the burn area were of clinical significance.
Experience in the treated group must be compared with the behaviour of PSR in the comparison group during the study. Development or progression of PSR in 31 comparison eyes must be balanced against evidence of autoinfarction in 17 patients and complete cure in 3. Furthermore the rapid progression in some patients was not reflected in deteriorating visual acuity. There is some evidence that the most rapid progression of PSR occurs in the 15-30 year age group,9 which includes 27 (47%) patients in the present study, and it is therefore possible that longer term follow-up will be associated with more complete regression of PSR.
In terms of visual acuity measured at the first and last attendance there was no significant difference between treatment and comparison groups over a mean 4-year follow-up period. In terms of vitreous haemorrhage an episode occurred in every 26-4 years of observation in the treatment group compared to 21 4 years of observation in the comparison group. However, the failure to demonstrate a difference between treatment and comparison groups must be treated with caution in view of the statistical limitations of the study. When the study was started in 1973, it was felt that the response to xenon arc photocoagulation in this condition was sufficiently unknown to justify treating only the worst affected eye. More data are now available, and if the problems of choroidal neovascularisation can be avoided there is a need for a proper randomly controlled trial of xenon arc therapy in PSR. With the realisation of the high prevalence of spontaneous autoinfarction, this study is especially necessary to define the role, if any, of photocoagulation in the therapy of these lesions.
